EE200100040A - Meetod raku fenotüüpi muutva modulaatori identifitseerimiseks ja valmistamiseks, sihtmärkbiomolekulide eraldamiseks ja/või samastamiseks ning meditsiinitoote arendamiseks ja valmistamiseks - Google Patents
Meetod raku fenotüüpi muutva modulaatori identifitseerimiseks ja valmistamiseks, sihtmärkbiomolekulide eraldamiseks ja/või samastamiseks ning meditsiinitoote arendamiseks ja valmistamiseksInfo
- Publication number
- EE200100040A EE200100040A EEP200100040A EEP200100040A EE200100040A EE 200100040 A EE200100040 A EE 200100040A EE P200100040 A EEP200100040 A EE P200100040A EE P200100040 A EEP200100040 A EE P200100040A EE 200100040 A EE200100040 A EE 200100040A
- Authority
- EE
- Estonia
- Prior art keywords
- identifying
- peptide
- methods
- rna
- producing
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 229940127554 medical product Drugs 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102000004190 Enzymes Human genes 0.000 abstract 2
- 108090000790 Enzymes Proteins 0.000 abstract 2
- 239000003596 drug target Substances 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 229940088598 enzyme Drugs 0.000 abstract 2
- 238000012216 screening Methods 0.000 abstract 2
- 229940122644 Chymotrypsin inhibitor Drugs 0.000 abstract 1
- 101710137926 Chymotrypsin inhibitor Proteins 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 abstract 1
- 240000005979 Hordeum vulgare Species 0.000 abstract 1
- 235000007340 Hordeum vulgare Nutrition 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 244000061456 Solanum tuberosum Species 0.000 abstract 1
- 235000002595 Solanum tuberosum Nutrition 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 239000003541 chymotrypsin inhibitor Substances 0.000 abstract 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 abstract 1
- 238000009509 drug development Methods 0.000 abstract 1
- 239000002532 enzyme inhibitor Substances 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 150000002611 lead compounds Chemical class 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1044—Preparation or screening of libraries displayed on scaffold proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1051—Gene trapping, e.g. exon-, intron-, IRES-, signal sequence-trap cloning, trap vectors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Computational Biology (AREA)
- Analytical Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA199800956 | 1998-07-20 | ||
| US9486898P | 1998-07-29 | 1998-07-29 | |
| PCT/DK1999/000408 WO2000005406A1 (fr) | 1998-07-20 | 1999-07-16 | Nouvelles techniques d'identification de ligand et de biomolecules cibles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200100040A true EE200100040A (et) | 2002-06-17 |
Family
ID=26064970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200100040A EE200100040A (et) | 1998-07-20 | 1999-07-16 | Meetod raku fenotüüpi muutva modulaatori identifitseerimiseks ja valmistamiseks, sihtmärkbiomolekulide eraldamiseks ja/või samastamiseks ning meditsiinitoote arendamiseks ja valmistamiseks |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1098991B1 (fr) |
| JP (1) | JP2002521652A (fr) |
| KR (1) | KR20010103560A (fr) |
| AT (1) | ATE223971T1 (fr) |
| AU (1) | AU751055B2 (fr) |
| CA (1) | CA2335343A1 (fr) |
| DE (1) | DE69902924T2 (fr) |
| DK (1) | DK1098991T3 (fr) |
| EA (1) | EA003637B1 (fr) |
| EE (1) | EE200100040A (fr) |
| HU (1) | HUP0102457A2 (fr) |
| NO (1) | NO20010300L (fr) |
| NZ (1) | NZ509013A (fr) |
| PL (1) | PL346126A1 (fr) |
| SK (1) | SK692001A3 (fr) |
| TR (1) | TR200100206T2 (fr) |
| WO (1) | WO2000005406A1 (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6365344B1 (en) | 1996-01-23 | 2002-04-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for screening for transdominant effector peptides and RNA molecules |
| DK0877752T3 (da) | 1996-01-23 | 2003-09-15 | Univ Leland Stanford Junior | Fremgangsmåder til screening af transdominante effektorpeptider og RNA molekyler |
| WO2001059071A2 (fr) | 2000-02-09 | 2001-08-16 | Genvec, Inc. | Methodes de preparation et d'utilisation d'une bibliotheque de vecteurs viraux |
| WO2002068630A1 (fr) * | 2001-02-22 | 2002-09-06 | Praecis Pharmaceuticals Incorporated | Procedes d'identification de peptides modulant un processus biologique |
| US6872544B2 (en) | 2001-09-25 | 2005-03-29 | Kemin Consumer Care, L.C. | Raw material selection and analysis for the isolation of proteinase inhibitor II from whole potatoes |
| EP1689766B1 (fr) * | 2003-11-06 | 2012-04-25 | Danisco US Inc. | Expression dans des champignons filamenteux d'inhibiteurs de protease et variants de ceux-ci |
| ATE482972T1 (de) * | 2003-11-06 | 2010-10-15 | Danisco Us Inc | Tgf-beta1-bindende und geträgerte peptide |
| JP4989638B2 (ja) * | 2005-06-10 | 2012-08-01 | メディカル リサーチ カウンシル | 足場 |
| US8043830B2 (en) * | 2008-02-01 | 2011-10-25 | The Regents Of The University Of California | Biotin-ligase system for secretion of biotinylated protein |
| US7803902B2 (en) | 2008-10-15 | 2010-09-28 | Danisco Us Inc. | Modified variant bowman birk protease inhibitors |
| BRPI0823193A2 (pt) * | 2008-10-15 | 2019-09-24 | Danisco Us Inc | inibidores de protease de bowman birk variantes modificados |
| US7772181B2 (en) | 2008-10-15 | 2010-08-10 | Danisco Us Inc. | Personal care compositions comprising modified variant Bowman Birk Protease Inhibitors |
| CN103808945B (zh) * | 2014-03-12 | 2016-02-10 | 山东农业大学 | 一种j亚群禽白血病免疫胶体金抗体检测试纸条 |
| US10876109B2 (en) | 2015-04-24 | 2020-12-29 | University Of Florida Research Foundation, Inc. | Methods of identifying biologically active random peptides in prokaryotic cells and libraries of prokaryotic cells expressing candidate biologically active random peptides |
| US10801023B2 (en) * | 2015-04-24 | 2020-10-13 | University Of Florida Research Foundation, Inc. | Methods of identifying biologically active random peptides in plants and libraries of plants expressing candidate biologically active random peptides |
| WO2016172445A2 (fr) * | 2015-04-24 | 2016-10-27 | The University Of Florida Research Foundation, Inc. | Procédés permettant d'identifier des peptides aléatoires biologiquement actifs dans des plantes et des bibliothèques de plantes exprimant des peptides aléatoires biologiquement actifs candidats |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996038553A1 (fr) * | 1995-06-02 | 1996-12-05 | M&E Biotech A/S | Procede d'identification de peptides et d'acides nucleiques biologiquement actifs |
| DK0877752T3 (da) * | 1996-01-23 | 2003-09-15 | Univ Leland Stanford Junior | Fremgangsmåder til screening af transdominante effektorpeptider og RNA molekyler |
| US6605429B1 (en) * | 1997-01-23 | 2003-08-12 | Immusol, Incorporated | Gene functional analysis and discovery using randomized or target-specific ribozyme gene vector libraries |
-
1999
- 1999-07-16 NZ NZ509013A patent/NZ509013A/xx unknown
- 1999-07-16 SK SK69-2001A patent/SK692001A3/sk unknown
- 1999-07-16 AT AT99932689T patent/ATE223971T1/de not_active IP Right Cessation
- 1999-07-16 JP JP2000561352A patent/JP2002521652A/ja active Pending
- 1999-07-16 KR KR1020017000871A patent/KR20010103560A/ko not_active Withdrawn
- 1999-07-16 EA EA200100160A patent/EA003637B1/ru not_active IP Right Cessation
- 1999-07-16 HU HU0102457A patent/HUP0102457A2/hu unknown
- 1999-07-16 DK DK99932689T patent/DK1098991T3/da active
- 1999-07-16 CA CA002335343A patent/CA2335343A1/fr not_active Abandoned
- 1999-07-16 EE EEP200100040A patent/EE200100040A/xx unknown
- 1999-07-16 WO PCT/DK1999/000408 patent/WO2000005406A1/fr not_active Ceased
- 1999-07-16 EP EP99932689A patent/EP1098991B1/fr not_active Expired - Lifetime
- 1999-07-16 PL PL99346126A patent/PL346126A1/xx not_active Application Discontinuation
- 1999-07-16 DE DE69902924T patent/DE69902924T2/de not_active Expired - Fee Related
- 1999-07-16 TR TR2001/00206T patent/TR200100206T2/xx unknown
- 1999-07-16 AU AU48985/99A patent/AU751055B2/en not_active Ceased
-
2001
- 2001-01-18 NO NO20010300A patent/NO20010300L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1098991B1 (fr) | 2002-09-11 |
| HUP0102457A2 (hu) | 2001-10-28 |
| NZ509013A (en) | 2002-12-20 |
| ATE223971T1 (de) | 2002-09-15 |
| KR20010103560A (ko) | 2001-11-23 |
| SK692001A3 (en) | 2001-12-03 |
| DE69902924T2 (de) | 2003-05-28 |
| EA200100160A1 (ru) | 2001-06-25 |
| DE69902924D1 (de) | 2002-10-17 |
| EA003637B1 (ru) | 2003-08-28 |
| JP2002521652A (ja) | 2002-07-16 |
| AU4898599A (en) | 2000-02-14 |
| NO20010300L (no) | 2001-03-19 |
| DK1098991T3 (da) | 2003-01-20 |
| NO20010300D0 (no) | 2001-01-18 |
| WO2000005406A1 (fr) | 2000-02-03 |
| PL346126A1 (en) | 2002-01-28 |
| TR200100206T2 (tr) | 2001-06-21 |
| AU751055B2 (en) | 2002-08-08 |
| EP1098991A1 (fr) | 2001-05-16 |
| CA2335343A1 (fr) | 2000-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jiang et al. | Oligonucleotide sequence mapping of large therapeutic mRNAs via parallel ribonuclease digestions and LC-MS/MS | |
| EE200100040A (et) | Meetod raku fenotüüpi muutva modulaatori identifitseerimiseks ja valmistamiseks, sihtmärkbiomolekulide eraldamiseks ja/või samastamiseks ning meditsiinitoote arendamiseks ja valmistamiseks | |
| Raines | Ribonuclease a | |
| US5827659A (en) | Methods and apparatus for sequencing polymers using mass spectrometry | |
| Meldal | The one‐bead two‐compound assay for solid phase screening of combinatorial libraries | |
| MX9708427A (es) | Serpina derivada de pancreas. | |
| ATE469979T1 (de) | Isolierung von biologischen modulatoren aus bibliotheken mit biologisch vielvältigen genfragmenten | |
| KR100204360B1 (en) | A method for identifying a polynucleotide molecule having a selected nucleic acid sequence from a library of random or semi-random polynucleotide molecules | |
| DE69831500D1 (de) | Humane checkpointkinase, hcds1, zusammensetzungen und verfahren | |
| Richardson et al. | Site-directed mutagenesis of rabbit proacrosin: Identification of residues involved in zona pellucida binding | |
| Deol et al. | The ubiquitin proteoform problem | |
| Jullien et al. | The role of proline residues in the folding kinetics of the bovine pancreatic trypsin inhibitor derivative RCAM (14–38) | |
| US10760084B2 (en) | α-amylase-binding nucleic acid molecule and use thereof | |
| Hu et al. | Simulation of evolution-selected propeptide by high-throughput selection of a peptidomimetic inhibitor on a capillary DNA sequencer platform | |
| Ruoppolo et al. | Identification of disulphide bonds in the refolding of bovine pancreatic RNase A | |
| US20040023292A1 (en) | Method and reagent for the detection of proteins and peptides | |
| YU4101A (sh) | Novi postupci za identifikovanje liganada i ciljnih biomolekula | |
| Chacón et al. | Snake Venomics of the Arboreal Talamancan Palm-Pitviper, Bothriechis nubestris, Provides Clues on the Origin of a Phenotypic Dichotomy between Type-I and Type-II Venoms | |
| Heyne et al. | Climbing up and down binding landscapes: a high-throughput study of mutational effects in homologous protein-protein complexes | |
| Willert et al. | Solid-phase combinatorial library of norstatine-type isosters by the nitroaldol reaction | |
| Strack | Designer proteases for post-translational modifications | |
| Bulygin et al. | Sites of 18S rRNA contacting mRNA 3′ and 5′ of the P site codon in human ribosome: A cross-linking study with mRNAs carrying 4-thiouridines at specific positions | |
| US20030049619A1 (en) | Methods for the synthesis of polynucleotides and combinatorial libraries of polynucleotides | |
| Claushuis et al. | In-depth specificity profiling of Pro-Pro endopeptidases (PPEPs) using combinatorial synthetic peptide libraries | |
| Huang et al. | Deep Protease Profiling to Define the Substrate Specificity of ADAMTS Proteases |